冠昊生物股价上涨1.42% 脑机接口政策推动产业创新

Core Viewpoint - Guanhao Biological is positioned to benefit from recent government policies aimed at promoting the development of brain-computer interface technology in the medical and health sectors [1] Company Summary - Guanhao Biological's latest stock price is 17.90 yuan, reflecting a 1.42% increase from the previous trading day [1] - The company operates in the medical device sector, focusing on the research and commercialization of regenerative medicine and life health products, including CAR-T cell therapy and medical aesthetics [1] Industry Summary - The Ministry of Industry and Information Technology and six other departments have issued implementation opinions to support the development of brain-computer interface enterprises, which may enhance the application of this technology in healthcare and wellness [1] - Guanhao Biological is identified as a relevant stock that could benefit from this industry policy support [1] Financial Summary - On the trading day, the opening price was 17.50 yuan, with a high of 18.07 yuan and a low of 17.44 yuan, resulting in a trading volume of 167,031 hands and a transaction amount of 297 million yuan [1] - The net outflow of main funds for Guanhao Biological on that day was 1.6346 million yuan, accounting for 0.03% of the circulating market value, while the cumulative net inflow over the past five trading days was 24.7885 million yuan, representing 0.52% of the circulating market value [1]